Turn recording back on
Modulating co-stimulation: a rational strategy in the treatment of rheumatoid arthritis?
Malmström V, Trollmo C, Klareskog L.
Arthritis Res Ther. 2005;7 Suppl 2:S15-20. Epub 2005 Mar 16. Review.
PMID: 15833144 [PubMed - indexed for MEDLINE]
Related Articles
The evolving clinical profile of abatacept (CTLA4-Ig): a novel co-stimulatory modulator for the treatment of rheumatoid arthritis.
Ruderman EM, Pope RM.
Arthritis Res Ther. 2005;7 Suppl 2:S21-5. Epub 2005 Mar 16. Review.
PMID: 15833145 [PubMed - indexed for MEDLINE]
Abatacept: A review of a new biologic agent for refractory rheumatoid arthritis for dermatologists.
Scheinfeld N.
J Dermatolog Treat. 2006;17(4):229-34. Review.
PMID: 16971318 [PubMed - indexed for MEDLINE]
Rheumatoid arthritis: beyond tumor necrosis factor-alpha antagonists, B cell depletion, and T cell blockade.
Manadan AM, Block JA.
Am J Ther. 2008 Jan-Feb;15(1):53-8. Review.
PMID: 18223354 [PubMed - indexed for MEDLINE]
B-cell: a logical target for treatment of rheumatoid arthritis.
Youinou P, Jamin C, Saraux A.
Clin Exp Rheumatol. 2007 Mar-Apr;25(2):318-28. Review.
PMID: 17543163 [PubMed - indexed for MEDLINE]
[Effect of CTLA4-Ig on radiographic outcome of patients with rheumatoid arthritis]
Harigai M.
Clin Calcium. 2007 Apr;17(4):577-84. Review. Japanese.
PMID: 17404488 [PubMed - indexed for MEDLINE]
Abatacept: a novel therapy approved for the treatment of patients with rheumatoid arthritis.
Lundquist L.
Adv Ther. 2007 Mar-Apr;24(2):333-45. Review.
PMID: 17565924 [PubMed - indexed for MEDLINE]
Role of abatacept in the management of rheumatoid arthritis.
Nogid A, Pham DQ.
Clin Ther. 2006 Nov;28(11):1764-78. Review.
PMID: 17212998 [PubMed - indexed for MEDLINE]
New therapeutics that treat rheumatoid arthritis by blocking T-cell activation.
MacKenzie NM.
Drug Discov Today. 2006 Oct;11(19-20):952-6. Epub 2006 Sep 7. Review.
PMID: 16997147 [PubMed - indexed for MEDLINE]
[CTLA4-Ig (abatacept)]
Nippon Rinsho. 2007 Jul;65(7):1231-7. Review. Japanese.
PMID: 17642237 [PubMed - indexed for MEDLINE]
Abatacept: a novel treatment for rheumatoid arthritis.
Lundquist LM.
Expert Opin Pharmacother. 2007 Oct;8(14):2371-9. Review.
PMID: 17927490 [PubMed - indexed for MEDLINE]
Abatacept: a costimulatory inhibitor for treatment of rheumatoid arthritis.
Teng GG, Turkiewicz AM, Moreland LW.
Expert Opin Biol Ther. 2005 Sep;5(9):1245-54.
PMID: 16120053 [PubMed - indexed for MEDLINE]
Drug Insight: abatacept for the treatment of rheumatoid arthritis.
Nat Clin Pract Rheumatol. 2006 Dec;2(12):654-60. Review.
PMID: 17133250 [PubMed - indexed for MEDLINE]
The role of B cells in rheumatoid arthritis: mechanisms and therapeutic targets.
Dörner T, Burmester GR.
Curr Opin Rheumatol. 2003 May;15(3):246-52. Review.
PMID: 12707577 [PubMed - indexed for MEDLINE]
Abatacept: the first T lymphocyte co-stimulation modulator, for the treatment of rheumatoid arthritis.
Chitale S, Moots R.
Expert Opin Biol Ther. 2008 Jan;8(1):115-22. Review.
PMID: 18081541 [PubMed - indexed for MEDLINE]
B cells, be gone--B-cell depletion in the treatment of rheumatoid arthritis.
Tsokos GC.
N Engl J Med. 2004 Jun 17;350(25):2546-8. No abstract available.
PMID: 15201410 [PubMed - indexed for MEDLINE]
Inhibiting costimulatory activation of T cells : a viable treatment option for rheumatoid arthritis?
Pollard LC.
Drugs. 2007;67(1):1-9. Review.
PMID: 17209660 [PubMed - indexed for MEDLINE]
Co-stimulatory blockade as therapy for rheumatoid arthritis.
Mackie SL, Vital EM, Ponchel F, Emery P.
Curr Rheumatol Rep. 2005 Oct;7(5):400-6. Review.
PMID: 16174492 [PubMed - indexed for MEDLINE]
Technology evaluation: abatacept, Bristol-Myers Squibb.
Dumont FJ.
Curr Opin Mol Ther. 2004 Jun;6(3):318-30. Review.
PMID: 15264435 [PubMed - indexed for MEDLINE]
The role of the T cell in autoimmune inflammation.
Skapenko A, Leipe J, Lipsky PE, Schulze-Koops H.
Arthritis Res Ther. 2005;7 Suppl 2:S4-14. Epub 2005 Mar 16. Review.
PMID: 15833146 [PubMed - indexed for MEDLINE]